Table 2.
Immunohistochemical staining results of the ulcerative colitis group
iNOS | COX-2 | Fas | Bcl-xl | Active caspase 3 | |
Patient A | |||||
UC | 0 | 0 | 1 | 0 | Positive |
Dysplasia | 3 | 0 | 3 | 2 | Positive |
Ca T3N2M0 | 1 | 0 | 3 | 3 | Positive |
Patient B | |||||
UC | 0 | 0 | 1 | 0 | Positive |
Dysplasia | 1 | 0 | 2 | 2 | Positive |
Ca T3N1M0 | 1 | 0 | 3 | 2 | Positive |
Patient C | |||||
UC | 0 | 0 | 1 | 0 | Positive |
Dysplasia | 1 | 0 | 1 | 1 | Positive |
Ca in situ TIS | 0 | 0 | 0 | 1 | Positive |
Patient D | |||||
UC | 0 | 0 | 1 | 0 | Positive |
Dysplasia | 1 | 0 | 3 | 1 | Positive |
Ca T1N0M0 | 1 | 0 | 3 | 3 | Positive |
Patient E | |||||
UC | 0 | 0 | 1 | 0 | Positive |
Dysplasia | 3 | 0 | 2 | 1 | Positive |
Ca T2N1M0 | 0 | 0 | 3 | 3 | Positive |
Immunohistochemical score: 0, 0%; 1, 0–10%; 2, 10–50%; 3, 50–100%.
Ca, carcinoma; COX-2, cyclooxygenase 2; iNOS, inducible nitric oxide synthase; UC, ulcerative colitis.